4.6 Article

Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: Dependence on glucose concentration and role of AMPK

James Sinnett-Smith et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Gastroenterology & Hepatology

Celecoxib synergizes human pancreatic ductal adenocarcinoma cells to sorafenib-induced growth inhibition

Ann H. Rosendahl et al.

PANCREATOLOGY (2012)

Article Medicine, General & Internal

Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

Sreenivasa Rao Kondapally Seshasai et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Gastroenterology & Hepatology

Diabetes and Pancreatic Cancer Chicken or Egg?

J. Trent Magruder et al.

PANCREAS (2011)

Article Endocrinology & Metabolism

Obesity related hyperinsulinaemia and hyperglycaemia and cancer development

Susen Becker et al.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2011)

Article Oncology

Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells

Mahvash Zakikhani et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Article Oncology

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

Andrea DeCensi et al.

CANCER PREVENTION RESEARCH (2010)

Article Oncology

Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis

Regan M. Memmott et al.

CANCER PREVENTION RESEARCH (2010)

Article Oncology

Metformin: A Therapeutic Opportunity in Breast Cancer

Ana M. Gonzalez-Angulo et al.

CLINICAL CANCER RESEARCH (2010)

Review Gastroenterology & Hepatology

Diabetes Mellitus in Pancreatic Cancer and the Need for Diagnosis of Asymptomatic Disease

A. Bartosch-Harlid et al.

PANCREATOLOGY (2010)

Article Endocrinology & Metabolism

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

C. J. Currie et al.

DIABETOLOGIA (2009)

Article Gastroenterology & Hepatology

Antidiabetic Therapies Affect Risk of Pancreatic Cancer

Donghui Li et al.

GASTROENTEROLOGY (2009)

Review Oncology

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

David B. Shackelford et al.

NATURE REVIEWS CANCER (2009)

Article Endocrinology & Metabolism

Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies

Paola Pisani

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)

Review Oncology

Insulin and insulin-like growth factor signalling in neoplasia

Michael Pollak

NATURE REVIEWS CANCER (2008)

Article Oncology

Prediagnostic plasma c-pepticle and pancreatic cancer risk in men and women

Dominique S. Michaud et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)

Article Oncology

Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies

Susanna C. Larsson et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Article Endocrinology & Metabolism

Prospective study of hyperglycemia and cancer risk

Par Stattin et al.

DIABETES CARE (2007)

Article Oncology

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

Mahvash Zakikhani et al.

CANCER RESEARCH (2006)

Article Biochemistry & Molecular Biology

Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity

A Hahn-Windgassen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Oncology

Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies

R Huxley et al.

BRITISH JOURNAL OF CANCER (2005)

Article Medicine, General & Internal

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults

EE Calle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Gastroenterology & Hepatology

Prevention of pancreatic cancer induction in hamsters by metformin

MB Schneider et al.

GASTROENTEROLOGY (2001)